GIORDANO, Giulia Maria
 Distribuzione geografica
Continente #
EU - Europa 5.309
AS - Asia 2.325
NA - Nord America 1.553
SA - Sud America 380
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 9.595
Nazione #
RU - Federazione Russa 3.898
US - Stati Uniti d'America 1.507
SG - Singapore 812
IE - Irlanda 479
CN - Cina 470
IT - Italia 438
HK - Hong Kong 434
BR - Brasile 323
KR - Corea 173
GB - Regno Unito 114
VN - Vietnam 114
JP - Giappone 106
DE - Germania 103
IN - India 77
TR - Turchia 58
FR - Francia 56
GR - Grecia 39
UA - Ucraina 39
FI - Finlandia 36
BD - Bangladesh 24
SE - Svezia 23
AT - Austria 21
AR - Argentina 20
MX - Messico 19
CA - Canada 18
ES - Italia 14
ZA - Sudafrica 13
IQ - Iraq 11
NL - Olanda 11
EC - Ecuador 9
PK - Pakistan 7
VE - Venezuela 7
CH - Svizzera 6
CL - Cile 6
CO - Colombia 6
CZ - Repubblica Ceca 5
ID - Indonesia 5
NO - Norvegia 5
PE - Perù 5
PL - Polonia 5
AZ - Azerbaigian 4
BE - Belgio 4
MA - Marocco 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
IL - Israele 3
NP - Nepal 3
PT - Portogallo 3
PY - Paraguay 3
AM - Armenia 2
CY - Cipro 2
DK - Danimarca 2
EG - Egitto 2
ET - Etiopia 2
EU - Europa 2
KE - Kenya 2
LV - Lettonia 2
NI - Nicaragua 2
RO - Romania 2
TT - Trinidad e Tobago 2
AU - Australia 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
DZ - Algeria 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
PA - Panama 1
PH - Filippine 1
SN - Senegal 1
TM - Turkmenistan 1
Totale 9.595
Città #
Moscow 1.368
Dublin 471
Hong Kong 431
Santa Clara 374
Singapore 360
Seoul 171
Chandler 155
Hefei 99
Jacksonville 97
Naples 88
Beijing 87
Aversa 77
Ashburn 67
Princeton 58
Roxbury 58
Istanbul 55
Bengaluru 49
Ho Chi Minh City 49
Cambridge 43
New York 41
The Dalles 30
Los Angeles 29
Caserta 28
Dallas 28
Bremen 26
Munich 24
São Paulo 22
Hanoi 19
Wilmington 19
Milan 18
Afragola 17
Des Moines 17
Medford 17
Boardman 13
Helsinki 13
Nuremberg 12
Falkenstein 10
Frankfurt am Main 10
Johannesburg 10
Rome 10
Turku 10
Viterbo 10
Da Nang 9
Lappeenranta 9
San Francisco 9
Rio de Janeiro 8
Vienna 8
Woodbridge 8
Brasília 7
Atlanta 6
Baghdad 6
Brooklyn 6
Norwalk 6
Stockholm 6
Belo Horizonte 5
Changsha 5
Chicago 5
Council Bluffs 5
Madrid 5
Manaus 5
Manchester 5
Marzano di Nola 5
Mexico City 5
Pune 5
Ribeirão Preto 5
Tulsa 5
Warsaw 5
Bergen 4
Brussels 4
Canoas 4
Etobicoke 4
Guarulhos 4
Jinan 4
Lima region 4
Nanjing 4
Nova Friburgo 4
Palo Alto 4
Porto Alegre 4
Quito 4
Redwood City 4
Sacramento 4
San Martino 4
San Mateo 4
Secaucus 4
Shanghai 4
Siano 4
Tashkent 4
Toronto 4
Venice 4
Ann Arbor 3
Arzano 3
Atibaia 3
Baku 3
Bogotá 3
Boston 3
Campinas 3
Casoria 3
Chennai 3
Ciampino 3
Curitiba 3
Totale 4.864
Nome #
A feasibility, acceptability and validation study of the Italian Version of a new cognitive remediation program for psychotic patients - CIRCuiTS 162
Aetiopathological mechanisms of negative symptoms in schizophrenia 157
A systematic review on shared biological mechanisms of depression and anxiety in comorbidity with psoriasis, atopic dermatitis, and hidradenitis suppurativa 157
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition 155
Cognitive Impairment after Post-Acute COVID-19 Infection: A Systematic Review of the Literature 145
A large European, multicenter, multinational validation study of the Brief Negative Symptom Scale 141
Abnormal bodily experiences detected by Abnormal Bodily Phenomena questionnaire are more frequent and severe in schizophrenia than in bipolar disorder with psychotic features 138
'Precision psychiatry' needs to become part of 'personalized psychiatry' 134
Assessment of the role of cognitive control on monetary reward and loss anticipation: An electrophysiological study in subjects with schizophrenia 133
Avolition-Apathy and White Matter Connectivity in Schizophrenia: Reduced Fractional Anisotropy Between Amygdala and Insular Cortex 132
Avolition and microstructural brain abnormalities in Schizophrenia: Reduced fractional anisotropy in pathways connecting amygdala and insular cortex 130
A Multivariate Analysis of Depression Prevalence in Psoriasis Patients: A Cohort Study 130
Advances in the understanding of the pathophysiology of schizophrenia and bipolar disorder through induced pluripotent stem cell models 128
Interview Versus Performance Assessment of Cognition as Predictors of Real-World Outcomes in a Large-Scale Cross-Sectional Study in Schizophrenia 119
The influence of autistic symptoms on social and non-social cognition and on real-life functioning in people with schizophrenia: Evidence from the Italian Network for Research on Psychoses multicenter study 119
The Cognitive Assessment Interview (CAI): Association with neuropsychological scores and real-life functioning in a large sample of Italian subjects with schizophrenia 118
Electrophysiological Correlates of Reward Anticipation in Subjects with Schizophrenia: An ERP Microstate Study 115
Mismatch Negativity and P3a Impairment through Different Phases of Schizophrenia and Their Association with Real-Life Functioning 115
A multivariate approach to investigate the associations of electrophysiological indices with schizophrenia clinical and functional outcome 114
Autism Rating Scale: A New Tool for Characterizing the Schizophrenia Phenotype 114
Investigating the Relationship between White Matter Connectivity and Motivational Circuits in Subjects with Deficit Schizophrenia: A Diffusion Tensor Imaging (DTI) Study 114
Updated perspectives on the clinical significance of negative symptoms in patients with schizophrenia 112
Accuracy of self-assessment of real-life functioning in schizophrenia 109
Sex and gender differences in clinical and functional indices in subjects with schizophrenia and healthy controls: Data from the baseline and 4-year follow-up studies of the Italian Network for Research on Psychoses 107
Neurobiology of Schizophrenia: Electrophysiological indices 107
Negative Symptom Domains in Children and Adolescents at Ultra-High Risk for Psychosis: Association with Real-Life Functioning 106
Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literature 106
EPA guidance on treatment of negative symptoms in schizophrenia 106
Effectiveness of a social cognition remediation intervention for patients with schizophrenia: a randomized-controlled study 106
The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients 105
Association of functional genetic variation in PP2A with prefrontal working memory processing 104
EEG-Based Measures in At-Risk Mental State and Early Stages of Schizophrenia: A Systematic Review 104
Clinical and psychological factors associated with resilience in patients with schizophrenia: data from the Italian network for research on psychoses using machine learning 104
Insight in cognitive impairment assessed with the Cognitive Assessment Interview in a large sample of patients with schizophrenia 103
The relationship between the resting state functional connectivity and social cognition in schizophrenia: Results from the Italian Network for Research on Psychoses 103
External validation of the five domains of negative symptoms: Focus on cognition, functional capacity, and real-world functioning 102
Correlations between Negative Symptoms and Cognitive Deficits in Individuals at First Psychotic Episode or at High Risk of Psychosis: A Systematic Review 102
Functional connectivity of the ventral tegmental area and avolition in schizophrenia: A resting state functional MRI study 102
Auditory P300 and cognition in schizophrenia: findings from a multicentre study 102
VTA-insula connectivity and avolition in subjects with schizophrenia 101
DISORGANIZATION AND COGNITIVE DYSFUNCTIONS IN SCHIZOPHRENIA: A STUDY OF RESTING STATE EEG 101
Neuroimaging: Diagnostic boundaries and biomarkers 101
EPA guidance on assessment of negative symptoms in schizophrenia 101
Assessment of Negative Symptoms in Schizophrenia: From the Consensus Conference-Derived Scales to Remote Digital Phenotyping 100
Resting-State Brain Activity Dysfunctions in Schizophrenia and Their Associations with Negative Symptom Domains: An fMRI Study 100
Gender Differences in Clinical and Psychosocial Features Among Persons With Schizophrenia: A Mini Review 100
ELECTROPHYSIOLOGICAL CORRELATES OF AVOLITION-APATHY DOMAIN IN SCHIZOPHRENIA 99
Improving Knowledge on Pathways to Functional Outcome in Schizophrenia: Main Results From the Italian Network for Research on Psychoses 99
Resting state functional connectivity of the ventral tegmental area and avolition in subjects with schizophrenia 98
Safety of electroconvulsive therapy (ECT) in pregnancy: a systematic review of case reports and case series 97
Illness-related variables and abnormalities of resting-state brain activity in schizophrenia 95
Current goals of neuroimaging for mental disorders: a report by the WPA Section on Neuroimaging in Psychiatry 95
Current limitations in technology-based cognitive assessment for severe mental illnesses: a focus on feasibility, reliability, and ecological validity 95
Research evidence on the management of the cognitive impairment component of the post-COVID condition: a qualitative systematic review 93
Factors Associated with Real-Life Functioning in Persons with Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses 93
Corrigendum: Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques (Front. Neurosci., (2020), 14, (632), 10.3389/fnins.2020.00632) 93
Social Cognition Impairments in 22q11.2DS Individuals With and Without Psychosis: A Comparison Study With a Large Population of Patients With Schizophrenia 92
Unveiling the Associations between EEG Indices and Cognitive Deficits in Schizophrenia-Spectrum Disorders: A Systematic Review 92
Impact of Reward and Loss Anticipation on Cognitive Control: An Event-Related Potential Study in Subjects With Schizophrenia and Healthy Controls 92
Neurophysiological correlates of Avolition-apathy in schizophrenia: A resting-EEG microstates study 90
Functional connectivity of the ventral tegmental area and avolition in subjects with schizophrenia: a resting state functional MRI study 90
Persistent negative symptoms in recent-onset psychosis: Relationship to treatment response and psychosocial functioning 89
Depression and neurocognitive impairment: evaluation of their role as predictors of auditory N100 in schizophrenia 89
Investigating the relationships of p3b with negative symptoms and neurocognition in subjects with chronic schizophrenia 89
Effects of chronic antipsychotic treatment on neurophysiological correlates of the auditory oddball task in schizophrenia: A preliminary report from a multicentre study 88
Disorganization and cognitive impairment in schizophrenia: New insights from electrophysiological findings 88
EPA guidance on assessment of cognitive impairment in schizophrenia 86
The association between insight and depressive symptoms in schizophrenia: Undirected and Bayesian network analyses 85
Relationship between MMN and real-life functioning in subjects with schizophrenia 84
Genome-wide association study detected novel susceptibility genes for social cognition impairment in people with schizophrenia 84
The structure stability of negative symptoms: longitudinal network analysis of the Brief Negative Symptom Scale in people with schizophrenia 83
Electrophysiological and neurocognitive correlates of the disorganization factor in schizophrenia 83
White matter structural connectivity abnormalities in subjects with deficit schizophrenia: A diffusion tensor imaging study 82
Electrophysiological correlates of negative symptom domains in schizophrenia 80
Joint structural-functional magnetic resonance imaging features are associated with diagnosis and real-world functioning in patients with schizophrenia 80
MMN impairment in subjects with schizophrenia among different stages of disease 79
Investigating the causal pathways among psychopathological variables, cognitive impairment, and real-life functioning in people with schizophrenia 78
Inter-rater reliability and psychometric characteristics of the Italian version of the Cognitive Assessment Interview (CAI) 77
Special Report on the Impact of the COVID-19 Pandemic on Clinical EEG and Research and Consensus Recommendations for the Safe Use of EEG 77
Switching Antipsychotic Medications in People with Schizophrenia: A 4-Year Naturalistic Study 76
Tracing Links Between Early Auditory Information Processing and Negative Symptoms in Schizophrenia: An ERP Study 76
Searching for bridges between psychopathology and real-world functioning in first-episode psychosis: A network analysis from the OPTiMiSE trial 75
Does social cognition change? Evidence after 4 years from the Italian Network for Research on Psychoses 75
Laryngopharyngeal reflux and psychological distress: a vicious cycle worth investigating 75
The efficacy, feasibility and acceptability of a remotely accessible use of circuits, a computerized cognitive remediation therapy program for schizophrenia: A pilot study 74
Prevalence of antipsychotic-induced extrapyramidal symptoms and their association with neurocognition and social cognition in outpatients with schizophrenia in the “real-life” 74
P3a and real-life functioning in a sample of chronic schizophrenia subjects 73
Prevalence of mental disorders and related risk factors in refugees and asylum seekers in Campania 72
Neglected Vulnerabilities in Mental Health: Where Do We Need to Do More? 72
We are not ready to abandon the current schizophrenia construct, but should be prepared to do so 72
EPA Guidance on treatment of cognitive impairment in schizophrenia 71
Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques 69
Negative symptoms and social cognition as mediators of the relationship between neurocognition and functional outcome in schizophrenia 68
Social cognition and real-life functioning in patient samples with 22q11.2 deletion syndrome with or without psychosis, compared to a large sample of patients with schizophrenia only and healthy controls 68
The dimensional structure of the Positive and Negative Syndrome Scale in first-episode schizophrenia spectrum disorders: an Exploratory Graph Analysis from the OPTiMiSE trial 67
Worldwide initiatives aimed to train professionals in the use of the ICD-11 67
Evolution of antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia in the real-life: A 4-year follow-up naturalistic study 66
Understanding the Pathophysiology of Mental Diseases and Early Diagnosis Thanks to Electrophysiological Tools: Some Insights and Empirical Facts 64
The Brief negative Symptom Scale (BNSS): a systematic review of measurement properties 63
European Validation of the Self-Evaluation of Negative Symptoms (SNS): A Large Multinational and Multicenter Study 62
Totale 9.757
Categoria #
all - tutte 33.410
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.410


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021105 0 0 0 0 0 1 35 2 14 6 37 10
2021/2022420 5 1 9 12 106 16 14 8 17 71 38 123
2022/2023791 72 23 25 40 66 53 10 28 417 10 19 28
2023/2024468 25 24 37 39 134 46 9 10 7 9 32 96
2024/20251.899 7 19 11 142 263 265 260 147 256 263 136 130
2025/20265.766 343 485 331 302 609 3.696 0 0 0 0 0 0
Totale 9.863